Oral microbiome therapy reduced Clostridioides difficile recurrence
1. SER-109, an oral microbiome therapy, showed superiority over placebo in reducing the recurrence of C. difficile infection. 2. SER-109 ...
1. SER-109, an oral microbiome therapy, showed superiority over placebo in reducing the recurrence of C. difficile infection. 2. SER-109 ...
1. Switching to placebo after week 18 resulted in greater elevations in serum bile acid levels and pruritus compared to ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.